Gruber & McBaine Capital Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Gruber & McBaine Capital Management’s Portfolio VYNT Stock Details VYNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$1.09M	Buy	619 +60	+11%	+$93.3K	0.3%	101
2015 Q1	$655K	Hold	559	–	–	0.17%	137
2014 Q4	$560K	Hold	559	–	–	0.15%	138
2014 Q3	$755K	Hold	559	–	–	0.21%	129
2014 Q2	$948K	Hold	559	–	–	0.25%	126
2014 Q1	$1.27M	Hold	559	–	–	0.33%	103
2013 Q4	$1.16M	Buy	+559	New	+$1.21M	0.3%	100

Other funds holding VYNT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return

Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Gruber & McBaine Capital Management's VYNT Position: Q2 2015 in Review

Gruber & McBaine Capital Management increased its Vyant Bio, Inc. Common Stock (VYNT) stake by 11% in Q2 2015, buying an estimated $93.3K and bringing the position to 619 shares worth $1.09M. The position accounts for 0.3% of the portfolio, ranked #101.

Gruber & McBaine Capital Management first reported a position in VYNT in Q4 2013 and has held it in 7 quarters since. The position peaked at $1.27M in Q1 2014. 36 funds tracked by Wall St. Rank hold VYNT as of Q2 2015.

Gruber & McBaine Capital Management held 619 shares of Vyant Bio, Inc. Common Stock worth $1.09M as of Q2 2015.
Gruber & McBaine Capital Management bought 60 Vyant Bio, Inc. Common Stock shares in Q2 2015, an estimated $93.3K.
Vyant Bio, Inc. Common Stock made up 0.3% of Gruber & McBaine Capital Management's portfolio in Q2 2015, its #101 holding.
Gruber & McBaine Capital Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2013 and has held it in 7 quarters since.
Gruber & McBaine Capital Management's Vyant Bio, Inc. Common Stock position peaked at $1.27M in Q1 2014.
36 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2015.

Based on Gruber & McBaine Capital Management's 13F filing for Q2 2015, filed 13 Aug 2015.